Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volixibat for pruritus in primary biliary cholangitis
NL-OMON60936Phase 2Active, not recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of volixibat in primary biliary cholangitis (PBC), sponsored by Mirum Pharmaceuticals, Inc. Started Sep 2024; status: active, not recruiting.
02
Drugs
volixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NL-OMON60936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60936.